Status:

RECRUITING

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Conditions:

Hypogammaglobulinemia

Multiple Sclerosis

Eligibility:

All Genders

18-65 years

Brief Summary

The investigators hypothesize that hypogammaglobulinemia (defined as IgG serum concentration \<7.0g/L) is a treatable cause of fatigue in people with MS: The primary objective is to prove the link be...

Detailed Description

Multiple sclerosis (MS) is the most common cause of mental and physical disability in young adults affecting approximately 10'000-15'000 persons in Switzerland (incidence 16/100000; prevalence 190/100...

Eligibility Criteria

Inclusion

  • Diagnosis of Multiple Sclerosis following McDonald 2017-Criteria
  • Age 18-65 years
  • Stable MS disease at inclusion (definition: no clinical relapse, no MRI activity, stable disability within the last 12 months)
  • Unchanged immunotherapy within the last 12 months
  • Expanded Disability Status Scale (EDSS) level \<4 points indicating fully ambulatory patients.
  • Capability of written informed consent

Exclusion

  • Severe depression (definition: Beck Depression Index-II (BDI-II) ≥29 points) or other established psychiatric diagnosis
  • Immunodeficiency other than hypogammaglobulinemia
  • Immunglobulin replacement therapy or indication for immunoglobulin replacement therapy
  • Severe Sleepiness (definition: Epworth-Sleepiness-Scale (ESS) \>16 points)
  • Fatigue aggravating factors such: liver/renal/thyroid dysfunction, substance abuse, medication (tranquilizers /antiepileptics/psychopharmaceuticals), chronic infectious disease (like hepatitis/HIV).
  • Other neurodegenerative/autoimmune disease.
  • Patients not able to give written consent
  • Vulnerable patients such as children, pregnant women and prisoners

Key Trial Info

Start Date :

July 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT05357781

Start Date

July 1 2022

End Date

December 30 2026

Last Update

March 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Bern Inselspital

Bern, Canton of Bern, Switzerland, 3010